semustine has been researched along with eflornithine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barranco, SC; Ford, PJ; Ho, BY; Koester, SK; Reumont, KJ; Townsend, CM | 1 |
| Alhonen-Hongisto, L; Deen, DF; Marton, LJ; Oredsson, SM; Pegg, AE | 1 |
2 other study(ies) available for semustine and eflornithine
| Article | Year |
|---|---|
Schedule dependent potentiation of antitumor drug effects by alpha-difluoromethylornithine in human gastric carcinoma cells in vitro.
Topics: Adenocarcinoma; Antineoplastic Agents; Bleomycin; Cell Cycle; Cell Survival; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Eflornithine; Fluorouracil; Humans; Ornithine Decarboxylase; Polyamines; Semustine; Stomach Neoplasms; Time Factors; Tumor Cells, Cultured | 1990 |
Possible factors in the potentiation of 1-(2-chloroethyl)-3-trans-4-methylcyclohexyl-1-nitrosourea cytotoxicity by alpha-difluoromethylornithine in 9L rat brain tumor cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Line; Cell Survival; Drug Synergism; Eflornithine; Ornithine; Polyamines; Rats; Semustine; Time Factors; Tumor Stem Cell Assay | 1984 |